Comparative Adherence Trajectories of Oral Fingolimod and Injectable Disease Modifying Agents in Multiple Sclerosis

BACKGROUND: Oral fingolimod is convenient to use than injectable disease modifying agents (DMAs) in patients with multiple sclerosis (MS). However, the existing literature regarding the comparative adherence trajectories between oral fingolimod and injectable DMAs is limited. OBJECTIVE: To compare t...

Descripción completa

Detalles Bibliográficos
Autores principales: Earla, Jagadeswara R, Hutton, George J, Thornton, J Douglas, Chen, Hua, Johnson, Michael L, Aparasu, Rajender R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7649232/
https://www.ncbi.nlm.nih.gov/pubmed/33177813
http://dx.doi.org/10.2147/PPA.S270557

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7649232/
https://www.ncbi.nlm.nih.gov/pubmed/33177813
http://dx.doi.org/10.2147/PPA.S270557

Ejemplares similares